{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:46:28Z","timestamp":1792853188506,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.xcrm.2024.101654","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:15:39Z","timestamp":1721128539000},"page":"101654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies"],"prefix":"10.1016","volume":"5","author":[{"given":"Lloyd D.W.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Quinkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia M.","family":"Lias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Silk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Pattinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ababacar","family":"Diouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnabas G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra A.","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Strazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Suurbaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Rees-Spear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Dabbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Carnrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Campeotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarel J.","family":"Fleishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy R.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S.","family":"MacGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Richter","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Birkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine A.","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ashfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-1357","authenticated-orcid":false,"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101654_bib1","series-title":"World Malaria Report","year":"2023"},{"key":"10.1016\/j.xcrm.2024.101654_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Rts","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101654_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101654_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1473-3099(23)00368-7","article-title":"Seasonal vaccination with RTS,S\/AS01(E) vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial","volume":"24","author":"Dicko","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101654_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101654_bib6","article-title":"Intermittent preventive treatment for malaria in children living in areas with seasonal transmission","volume":"2012","author":"Meremikwu","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.xcrm.2024.101654_bib7","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1016\/j.vaccine.2023.04.011","article-title":"Modelling the relative cost-effectiveness of the RTS,S\/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis","volume":"41","author":"Topazian","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2024.101654_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria Vaccines: Recent Advances and New Horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2024.101654_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003943","article-title":"Plasmodium falciparum erythrocyte invasion: combining function with immune evasion","volume":"10","author":"Wright","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101654_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ncomms1615","article-title":"The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody","volume":"2","author":"Douglas","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101654_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.pt.2020.04.003","article-title":"The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target","volume":"36","author":"Ragotte","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2024.101654_bib12","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41564-022-01261-2","article-title":"PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","author":"Scally","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2024.101654_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-023-06856-1","article-title":"The PfRCR complex bridges malaria parasite and erythrocyte during invasion","volume":"625","author":"Farrell","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101654_bib14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10606","article-title":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum","volume":"480","author":"Crosnier","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101654_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chom.2016.06.004","article-title":"Essential Role of the PfRh5\/PfRipr\/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes","volume":"20","author":"Volz","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2024.101654_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000490","article-title":"Resurrection of the ancestral RH5 invasion ligand provides a molecular explanation for the origin of P. falciparum malaria in humans","volume":"17","author":"Galaway","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.xcrm.2024.101654_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.chom.2014.11.017","article-title":"A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys","volume":"17","author":"Douglas","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2024.101654_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96381","article-title":"Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2024.101654_bib19","first-page":"668","article-title":"Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults","volume":"4","author":"Silk","year":"2023","journal-title":"M\u00e9d."},{"key":"10.1016\/j.xcrm.2024.101654_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-018-0071-7","article-title":"Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells","volume":"3","author":"Jin","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xcrm.2024.101654_bib21","first-page":"701","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","author":"Minassian","year":"2021","journal-title":"M\u00e9d."},{"key":"10.1016\/j.xcrm.2024.101654_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00312-8","article-title":"Blood-stage malaria vaccine candidate RH5.1\/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial","author":"Silk","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101654_bib23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41467-019-09894-4","article-title":"A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates","volume":"10","author":"Douglas","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101654_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2018.00524","article-title":"Plasmodium falciparum Liver Stage Infection and Transition to Stable Blood Stage Infection in Liver-Humanized and Blood-Humanized FRGN KO Mice Enables Testing of Blood Stage Inhibitory Antibodies (Reticulocyte-Binding Protein Homolog 5) In\u00a0Vivo","volume":"9","author":"Foquet","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101654_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101654_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3389\/fimmu.2018.01432","article-title":"New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue","volume":"9","author":"Brune","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101654_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02931","article-title":"A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response","volume":"10","author":"Marini","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101654_bib28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4254\/wjh.v7.i18.2127","article-title":"Three decades of hepatitis B control with vaccination","volume":"7","author":"Meireles","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101654_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101654_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep30357","article-title":"Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system","volume":"6","author":"Hjerrild","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101654_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijpara.2016.12.001","article-title":"Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag","volume":"47","author":"Jin","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.xcrm.2024.101654_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.1616903114","article-title":"One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen","volume":"114","author":"Campeotto","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101654_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101654_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.1302045","article-title":"Neutralization of Plasmodium falciparum Merozoites by Antibodies against PfRH5","volume":"192","author":"Douglas","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2024.101654_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14333","article-title":"P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5","volume":"8","author":"Galaway","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101654_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01566-20","article-title":"The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site","volume":"11","author":"Campeotto","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2024.101654_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/mmi.14904","article-title":"The Plasmodium falciparum parasitophorous vacuole protein P113 interacts with the parasite protein export machinery and maintains normal vacuole architecture","volume":"117","author":"Bullen","year":"2022","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.xcrm.2024.101654_bib38","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/s41467-023-37890-2","article-title":"Plasmepsin X activates the PCRCR complex of Plasmodium falciparum by processing PfRh5 for erythrocyte invasion","volume":"14","author":"Triglia","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101654_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83681","article-title":"Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes","volume":"12","author":"Jamwal","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2024.101654_bib40","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/acs.bioconjchem.2c00030","article-title":"Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery","volume":"33","author":"Olshefsky","year":"2022","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.xcrm.2024.101654_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like particle vaccinology, from bench to bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2024.101654_bib42","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/jvi.67.8.4588-4597.1993","article-title":"Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein","volume":"67","author":"Mangold","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101654_bib43","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research","volume":"23","author":"Heppner","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2024.101654_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12916-018-1186-4","article-title":"Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S\/AS01E vaccination in African children","volume":"16","author":"Ubillos","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.xcrm.2024.101654_bib45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41467-022-28601-4","article-title":"Heterotypic interactions drive antibody synergy against a malaria vaccine candidate","volume":"13","author":"Ragotte","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101654_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2019.03.020","article-title":"Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans","volume":"27","author":"Rijal","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101654_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101654_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101654_bib47","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2024.101654_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for Structure Building and Analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci. : a publication of the Protein Society"},{"key":"10.1016\/j.xcrm.2024.101654_bib49","article-title":"Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype","author":"Barrett","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2024.101654_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2024.101654_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002991","article-title":"Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens","volume":"8","author":"Williams","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101654_bib54","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"Malkin","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2024.101654_bib55","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.4049\/jimmunol.181.12.8776","article-title":"Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination","volume":"181","author":"Miura","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2024.101654_bib56","article-title":"Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies","volume":"2","author":"Willcox","year":"2021","journal-title":"Cell Rep. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T13:59:30Z","timestamp":1728395970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124003689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2666379124003689"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101654","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.04.574181","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101654"}}